Braveheart Investment Group acquired a 33% stake in Pharm2Farm.

Braveheart Investment Group, the fund management and strategic investor group, acquired a 33% stake in Pharm2Farm, a spin out from Nottingham Trent University. NTU and P2F have developed and patented a process to increase the bioavailability of trace minerals in plant feeds. Their patented process uses nanotechnology to dramatically improve trace element take-up in both flower and crop farming. P2F produce and sell these products through an exclusive licence to this technology from NTU. Financial terms were not disclosed.